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Abstract.  We have previously shown that the human 
pS2 gene,  which codes for a  secreted peptide of 60 
amino  acids,  is expressed in a  number of human  car- 
cinomas,  including  carcinomas  of the breast,  the pan- 
creas,  and the large bowel. Strong pS2 gene expression 
was also observed in the normal  gastric  mueosa and in 
the regenerative  tissues surrounding  ulcerous lesions 
of the gastrointestinal  tract.  A  number of pS2  similar 
peptides,  designated  as P-domain peptides,  have been 
described,  notably the porcine (PSP),  murine  (mSP), 
and human (hSP) spasmolytic polypeptides, which cor- 
respond to duplicated pS2 proteins.  We have now 
cloned a  mouse homolog of the human pS2 eDNA to 
dispose of an animal  model to study the pS2 protein 
function,  which remains unknown at the present time. 
We show that the mouse putative pS2 protein sequence 
and the physiological pattern  of expression  of the 
mouse pS2 gene are well conserved.  The mouse pS2 
gene is highly expressed in the stomach mucosa cells, 
whereas no pS2 gene expression could be detected in 
the mouse mammary  gland,  even during postnatal  de- 
velopment processes dependent on growth factors or 
hormones.  Using in situ hybridization,  we show that 
although  coexpressed in the fundus,  the antrum  and 
the antrum-pyloric  regions of the stomach,  the mouse 
pS2 and mSP genes exhibit distinct  and complemen- 
tary cellular patterns  of expression. 
T 
HE human pS2 gene codes for a  small preprotein of 
84  amino  acids,  containing  at  its  amino  terminus 
a  signal  peptide  characteristic  of secreted  proteins 
(Masiakowski et al.  1982; Jakowlev et al.,  1984). The se- 
creted mature protein  is 60 amino acids long  (Rio et al., 
1988a).  The pattern of expression of the human pS2 gene, 
in normal and pathological tissues, is well documented (for 
review see Rio and Chambon,  1990). ThepS2 gene was first 
reported to be expressed in 50% of human breast carcino- 
mas, and in some of their associated lymph node metastases 
(Rio et al.,  1987), but its expression is not specific to estro- 
gen receptor positive carcinomas of the manunm~ gland, as 
pS2 mRNA and protein were also observed in carcinomas 
of the pancreas (70-75 %) (Welter et al.,  1991; Henry et al., 
1991a), stomach (50-55%) (Luqmani et al.,  1989; Henry et 
al., 1991a), large bowel (58%) (Henry et al., 1991a), biliary 
tract (Seitz et al.,  1991), and in a mutinous subtype of ovar- 
ian tumors  (Guerin  et al.,  1990;  Theisinger  et al.,  1991; 
Henry et al.,  1991a).  The pS2 gene was also shown to be 
physiologicaly expressed in the normal gastric mucosa (Rio 
et al.,  1988b), and in the regenerative tissues surrounding 
ulcerous lesions of the human gastrointestinal  tract (Rio et 
al.,  1991). 
In all tissues expressing the pS2 protein, immunocytologi- 
cal staining was observed in the cytoplasm of epithelial cells, 
with a preferential perinuclear accumulation. The regulation 
of pS2 gene expression is tissue specific. In in vitro culture 
of tumoral mammary epithelial cells, pS2 gene expression is 
estrogen-dependent  (Berry et al.,  1989).  In vivo, the pS2 
protein  is  predominantly  expressed  in  estrogen  receptor- 
positive breast carcinomas (Rio et al.,  1987;  Henry et al., 
1989; Wysocki et al.,  1990), and is indicative of a favorable 
response  to hormonotherapy  (Henry et al.,  1989,  1991b; 
Schwartz et al.,  1991;  Klijn et al.,  1992). However, no es- 
tradiol receptors have been found in the gastrointestinal tract 
and, in this tissue, the expression of the pS2 gene could be 
dependent on EGF (Wright et al.,  1990a).  In fact,  the 5' 
flanking region of the pS2 gene contains a complex enhancer 
region responsive to oestrogen,  EGF,  the tumor promoter 
TPA, and the proto-oncoproteins c-Ha-ras and c-jun (Nunez 
et al.,  1989). 
Very little is known concerning the possible function of the 
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with the porcine pancreatic spasmolytic polypeptide (PSP) m 
(Thim,  1988;  Backer, 1988),  which appears to correspond 
to a duplicated pS2 protein and is produced in large amounts 
by the exocrine pancreas, and has been shown to have spas- 
molytic and gastric acid secretion inhibitory effects (Jorgen- 
sen et al.,  1982).  The mouse (raSP) and the human (hSP) 
counterparts of PSP have been cloned, and found to be ex- 
pressed within normal stomach mucosal cells (Tomasetto et 
al.,  1990).  Moreover, three pS2 similar proteins, xP1, xP2 
and xP4, have been identified in Xenopus, and are e~tpressed 
in the stomach mucosa (xPl,  xP4)  (Hauser and Hoffman 
1991), and in the skin (xP2) (Hauser et al., 1992). Recently, 
a new member of the family, intestinal trefoil factor (ITF), 
has been identified in rat intestinal mucosa (Suemori et al., 
1991). All the members of this family of proteins exhibit one 
(pS2, xP1, ITF), two (PSE mSE hSE xP2), or four copies 
(xP4) of a domain containing strikingly conserved cysteine 
residues, named the P-domain (Tomasetto et al., 1990), that 
is presumed to participate in a trefoil disulphide loop struc- 
ture (Thim, 1989; Carr, 1992) and to contribute to the pro- 
tease  resistance of these proteins.  In fact,  PSP  has been 
shown to be resistant to a number of proteases, despite the 
presence of multiple potential proteolytic sites,  and to exert 
biological activity when given by an oral route to animals 
(Jorgensen et al., 1982). All of these results suggest that the 
P-domain peptides could be involved in the maintenance of 
mucosal integrity (Suemori et al., 1991). This action may re- 
sult from a growth factor-like role of the P-domain peptides, 
a role previously proposed for pS2 (Jakowlev  et al.,  1984) 
based on structural similarities with such factors. 
To investigate further the biological function of the pS2 
protein, we have now cloned the mousepS2 cDNA, and ana- 
lyzed the physiological pattern ofpS2 gene expression in this 
animal, particularly in the mammary gland during postnatal 
development and in perinatal and adult gastrointestinal tract. 
Our results show that the pS2 protein sequence and expres- 
sion pattern are well conserved between human and mouse. 
No pS2 mRNA was found in mammary gland samples, but 
the mouse pS2 gene is physiologically expressed in mucosal 
cells of the stomach where it can be detected from the 17th 
day of gestation. Comparison of the pS2 and mSP gene pat- 
terns of expression, by in situ analysis on serial sections, re- 
veals that the one P-domain (pS2)  and the two P-domain 
(mSP) peptides are specifically expressed in different tissues 
and/or at different cellular levels in the mouse gastrointesti- 
nal tract showing spatial complementarity. 
Materials and Methods 
7issue Collection 
Part of the tissue samples were immediately frozen in liquid nitrogen for 
RNA extraction.  The remainder of the tissue was conserved in formol be- 
fore inclusion in paraffin for histological examination and in situ hybridiza- 
tion. Perinatal gastrointestinal  tissues (collected daily from 14 d of gestation 
to 3 d after birth, and 7, 14, and 21 d posmatally) were dissected under the 
binocular microscope,  and immediately fixed in formol. 
1. Abbreviations used in this paper: hSP, human spasmolytic  polypeptide; 
mSP,  mouse  spasmolytic polypeptide;  PSP,  porcine  spasmolytic  poly- 
peptide. 
Mammary glands were surgically excised from virgin mice (before and 
after sexual maturity), pregnant mice at various stages of gestation, lactat- 
ing mice (when the lobulo-alveolar development was complete), and after 
weaning (during involution of the lobulo-alveolar structures). 
Isolation of  RNA and Northern Hybridization 
RNA was prepared by a single-step  method by acid guanidinium  thiocyanate- 
phenol-chloroform extraction (Chomczynski and Sacchi,  1987).  RNAs 
were fractionated by gel agarose electrophoresis (1%) in the presence of 
formaldehyde and transferred to nylon membranes (hybond N; Amersham 
International, Amersham, UK).  Filters were acidified (10 rain, 5% CH3- 
COOH) and stained (10 rain, 0.004% methylene blue, 0.5 M CH3COONa, 
pH 5.0) before hybridization.  Double-stranded DNA was 32p-labeled by 
random-priming (Feinberg and Vogelstein,  1983). Northern blots were hy- 
bridized for 18 h under stringent  conditions (50% formamide, 420C). Wash- 
ings were performed in 2x SSC, 0.1% SDS at 22°C, followed by 0.1x SSC, 
0.1% SDS at 55°C. 
cDNA Synthesis 
1 /tg of poly(A)  + RNA, purified  by oligo(dT)-cellulose  chromatography 
from mouse stomach total RNA, was heated at 65°C for 3 rain, in 16.5 #1 
of water, quenched on ice, added to 2 #1 of 10X RTC buffer (Ix  =  50 mM 
Tris-HCL, pH 8.15, at 41oc, 6 mM MgC12, 40 mM KC1, 1 mM DTT, each 
dNTP at 1.5 raM), 0.25/zl (10 U) of RNasin (Promega Biotec,  Madison, 
WI), 0.5/~1 of EcoR1 adaptor-(dT)18  primer (5'CCCTCGAGGATCCGA- 
ATTC18X(dT)3~ (1/zg//d), and 10 U of AMV-reverse transcriptase (avian 
myeloblastosis virus), and incubated for 1.5 h at 42°C. The reaction mixture 
was diluted to 1 ml with TE buffer (10 mn Tris-HCl, pH 7.5, 1 mM EDTA) 
and stored at 4°C. 
Amplification of 3' End cDNA Sequences Related 
to P-Domain Peptides 
Comparison of human pS2, raSP, and hSP cDNA sequences allowed us to 
define  an  oligonucleotide  5'CCGAATTCGGATCCCTCAACTG~T- 
TCCC~3',  capable of identifying the coding region of the mouse pS2 
gene. It was constituted by 18 highly conserved nucleotides,  located in the 
5' end of the P-domain sequence (Tomasetto et al., 1990). Recognition se- 
quence for EcoR1 endonuclease was added to create a restriction site at the 
5' end of the oligonucleotide.  Using this specific adaptor-primer and the 
nonspecific  adaptor-oligo(dT)  primer,  cyclic  thermal amplification  with 
Taq-polymerase (Perkin-Elmer Corp., Norwalk, CT) was according to Froh- 
man et al. (1988).  PCR reactions were performed in a final volume of 50 
/zl covered with 100/~1 mineral oil. Reaction included 5 #i of 10x  PCR 
buffer (Tris-HCl  100 mM, pH 8.3; KCI 500 mM; MgCI2 15 raM; Gelatin 
0.01%  ), 250 #M of  each dNTP, 0.5/zM of  the 5' amp specific adaptor-primer, 
0.5/~M of the 3' amp adaptor-oligo(dT)  primer and 2.5 U of Cetus Taq poly- 
merase. Initial denaturation was for 5 rain at 95°C,  annealed for 2 rain at 
50°C and then the cDNA was extended for 40 rain at 72°C.  Amplification 
was for 40 cycles (40 s at 94°C,  2 rain at 50oC, 3 min at 72°C) followed 
by 15 rain final extension at 720C. 10/zl of the PCR product were analyzed 
on 1% agarose gel containing ethidium bromide at 0.5/~g/ml. Material from 
amplification (,,,250-500 bp) was extracted after electrophoresis on a low 
melting point agarose gel (GIBCO BRL, Gaithersburg, MD), EcoRI di- 
gasted and cloned in the Bluescript vector (SK+; Stratagene  Ltd., Cam- 
bridge, UK), so as to obtain a ~mini-library" enriched in P-domain peptide 
sequences.  After transfection in XL1Blue bacteria, the library was plated 
on 6 petri dishes, at low density (40 colonies per petri dish), and replicated 
on nylon filters (Biodyne A; Pall Corporation, Glen Cove, NY).  160 recom- 
binants were first hybridized with a 32P-labeled mSP probe (TomaseRo et 
al., 1990), at 42°C in the presence of 50% formamide.  Washings were per- 
formed in 2x SSC, 0.1% SDS at 220C, followed by 0.1x SSC, 0.1% SDS 
at 55°C.  After autoradiography,  the remalnding negative clones (only  10) 
were sequenced  by the dideoxy protocol employing  Sequenase and dGTP 
analogs. The same conditions of  hybridization were used to screen the lambda 
GT10 mouse stomach library with the previously  isolated  cDNA and to 
sequence the positive clones, amplified  after subcloning in the bluescript 
vector. 
In situ Hybridization 
Deparaffined  and acid-treated sections (6/zm thick) were treated with pro- 
teinase K and hybridized  overnight with 35S-labeled antisense transcripts 
The Journal of Cell Biology, Volume 122, 1993  192 CCATGGAGCACAAGGTGATCTGTGTCCTCGCTGTGGTCCTCATGCTGGCCTTCGGCAGTCTTGCCCAGGCCCAG  74 
M  E  H  K  v  I  C  v  L  A  V  V  L  M  L  A  F  G  S  L  AtQ  A  Q  24 
GC  CCAGGCCCAGGCCCAGGAAGAAACATGTATCATGGCCC  CCCGGGAGAGGATAAATTGTGGCTTCCC  CGGTGTC  149 
A  t Q  A  Q  A  Q  E  E  T  C  I  M  A  P  R  E  R  I  N  C  G  F  P  G  V  49 
ACCGCCCAGCAGTGCACGGAGAGAGGTTGCTGTTTTGATGACAGTGTCCGGGGATTCCCGTGGTGCTTCCACCC  C  224 
T  A  Q  Q  C  T  E  R  G  C  C  F  D  D  S  V  R  G  F  P  W  C  F  H  P  74 
ATGGCCATCGAGAACACTCAAGAAGAAGAATGTCCCTTCTAAGGTCCATCCTGAGAGAACTGGCTACATCAAGAC  329 
M  A  I  E  N  T  Q  E  E  E  C  P  F  *  88 
TTGGCACCCTCCACCTGGGCACTGGAGCCACCTGGCCCACCTGCTACATACACACCTATTCTGTGGCTGGATCTG  374 
GCTGGTGACACAGTTCAACCCCTCAGACTTTTAGTCCTCGAATTCGGCCTGAGAATTAAAAGAGATGAATGTTAA  449 
AAAAAAAAAAAAAAA  464 
Figure l. Mouse pS2 eDNA and its deduced amino acid sequence. 
Nucleotide residues are numbered in the 5' to 3' direction and amino 
acids in the open reading frame are designated by the one letter 
code. The 5~,A'VIG~JCd2TTCCCCGGT3'  sequence correspond- 
ing to the P-domain specific primer is underlined.  Arrows indicate 
the two putative signal peptidase sites (Yon Heijne,  1986). These 
sequence data are available from EMBL/GenB~k/DDBI under ac- 
cession number Z21858. 
from apS2- or a mSP-cDNA  insert, subcloned  in Bluescript II (Stratagene). 
Hybridization  was followed  by RNase  treatment  (20/~g/ml, 30 rain, 37°C) 
and two stringent washings (2x SSC, 50% formamide,  60°C, 2 h), before 
autoradiography using NTB2 emulsion (Easmmn Kodak Co., Rochester, 
NY). Autoradiography was for 36 h to 4 d. 
Results 
Identification of  Mouse pS2 Coding Sequences 
Assuming that the physiological expression of the pS2 gene 
in  the  stomach  may  be  conserved  between  human  and 
mouse, a eDNA library, enriched in P-domain peptide se- 
quences,  was  constructed  from  mouse  stomach  tissue. 
mRNAs isolated  from mouse stomach were reverse tran- 
scribed  and  amplified by  PCR  using  an  EcoR1  adaptor- 
oligo(dT)primer and  an EeoRI adaptor-P-domain specific 
primer, deduced by comparison of published sequences of 
human pS2,  raSP and hSP (see Materials  and  Methods). 
250-500 bp-long eDNA PCR products, were cloned at the 
EcoRI site of a bluescript vector after elution from low melt- 
ing gel.  160 recombinant clones were first screened with a 
32p-labeled raSP probe to eliminate all clones containing se- 
quences related to the mSP gene (150 clones). The ten re- 
maining clones were sequenced. One of them, containing a 
245-bp insert, corresponded to a putative 45-amino acid se- 
quence,  closely  related  (67%  homology)  to  the  COOH- 
terminal part of the human pS2 protein.  This cDNA was 
used to probe a lambda GTI0 mouse stomach eDNA library 
(Tomasetto et al.,  1990) to isolate the corresponding full- 
length  eDNA.  20 positive clones were obtained;  three of 
them were subcloned into a bluescript vector and sequenced, 
yielding a potential mouse pS2 eDNA of 464 bp in length 
(Fig.  1). 
The Mouse and Human pS2 Protein Sequences 
Are Highly Homologous 
The protein sequence, as deduced from the eDNA sequence 
(Fig. 1), was 87 amino acid residues in length and contained 
a  hydrophobie NH2-terminal sequence corresponding to a 
putative signal peptide of either 21 or 25 residues, according 
to possible cleavage sites (Von Heijne,  1986). The putative 
mature protein,  made up of either 62 or 66 amino acids, 
showed a mean similarity of 67 and 47% with the human and 
Xenopus (xP1)  pS2 proteins,  respectively, and an absolute 
conservation of the six consensus cysteine residues present 
in the P-domain (Fig. 2). Moreover, 49 and 39% similarity 
were also observed with the first and the second P-domains 
of mSP,  respectively (Fig.  2).  The highest  similarity was 
with the human pS2 protein suggesting that the cloned eDNA 
corresponded indeed to the mouse pS2 eDNA. 
In addition to the conservation of the consensus cysteine 
residues, a strong similarity was also seen in residues adja- 
cent to the sites of presumed intrachain disulfide bond for- 
marion (Fig.2, consensus sequence). Moreover, the last six 
COOH-terminal  amino  acids  of the  mouse  pS2  protein, 
showed 83 % similarity with the human peptide sequence. In- 
terestingly, this part of the pS2 protein corresponds to the 
third exon of the human pS2 gene, and, of all members of 
the P-domain family, only the mouse and human pS2 possess 
this acidic motif. Independently of the cleavage site of the 
signal peptidase, the secreted mature form of the mouse pS2 
protein, contains a glutamine at its NH2-terminal end. This 
NH~-terminal residue  was  already  observed in  PSP,  xP1, 
and xP2, whereas human pS2, mSP, hSP and xP4 display an 
NH2-terminal glutamie acid. Both glutamic acid and gluta- 
mine residues could be enzymatieally changed into a pyro- 
glutamie acid residue, as previously observed for pS2 in gas- 
tric juice (Rio et al.,  1988a) and PSP (Thim et al.,  1985), 
suggesting that the same posttranslational modification could 
exist in the mouse pS2 peptide. 
xP1  -h'Y-  -F-.. L-AIA-  IV-  - IGS  -N~--Ar?--O  .  SVEP..~  V  YS  r-P-E  -KO-  -STIODA  Y  R-TPm" 
raSP  aPa~PL---r~-V  ...... aALVE~KPSPCR  s~T-m~  K  --  I-SE-  FDL-  -S--A-V  -  LPNQESEQ 
LLI "v-~v~AL3~l  ---I  ~-LLI ~P~DI -I A~-"I---I sN=~!C~  q-I ~-~ 
CONSENSUS  c  .......  R  -  NCG  FP  G  IT  C  G  CCF  D  V  PWCF  -  P 
YS  VS ......  N  S--I  n- 
Figure 2. Sequence conserva- 
tion between the mouse (rapS2), 
human  (hpS2) and  Xenopus 
(xP1) one P-domain peptide, 
and  the  murine  (mSP) two 
P-domain peptide. Amino acid 
sequences  determined  from 
cDNA  sequence  data  have 
been aligned.  Gaps (.)  have 
been introduced  into  the  se- 
quences  to  obtain  maximal 
alignment of identical amino acids. The complete one letter code sequence is given for mpS2; in the sequence of hpS2, xP1, and mSP, 
only nonconserved amino acids are indicated;  (-) represents the conserved amino acids. Invariant amino acids, observed in the four se- 
quences,  are enclosed in boxes. Stars indicate the acidic COOH-terminal  part, specific to the mouse and human pS2 proteins.  Arrows 
indicate the putative signal peptidase sites (Von Heijne,  1986), whereas the arrowhead indicates the defined signal peptidase site (Rio et 
al.,  1988a).  Consensus  sequence established  from the four sequences is also given. 
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lane contained 10 #g of total RNA. From left to right: muscle, 
lung, uterus, kidney, spleen, brain, liver, testis, small intestine, 
colon, heart, skin, and stomach. A 600-base-long pS2 transcript 
was detected in lanes 3 and 13, corresponding to uterus and stom- 
ach. The 36B4  probe (Masiakowski  et al., 1982) was used as posi- 
tive internal control. Autoradiography was overnight for 36B4 hy- 
bridization  and pS2 hybridization  in the stomach (lane 13), whereas 
pS2 hybridization of all other samples are exposed for 2 d. 
The pS2 Gene Is Highly Expressed in Mouse Stomach 
Northern blot analysis of total RNA from a panel of normal 
mouse tissues, using a 32p-labeled mouse pS2 eDNA corre- 
sponding to the complete coding sequence, revealed a single 
pS2 transcript of 600 bases in the stomach (Fig. 3, lane 13), 
whereas muscle, lung, kidney, spleen, brain,  liver, testis, 
small intestine, colon, heart,  skin (Fig.  3,  lane 1,  2,  and 
4-12), and pancreas (data not shown) were negative. An un- 
expected, very weak response was also observed in a mouse 
uterine sample (Fig.  3,  lane 3).  Since the normal human 
uterus does not express thepS2 gene (Rio et al., 1987; Henry 
et al., 1991a; Piggot et al., 1991), we cannot exclude that this 
low hybridization signal resulted from cross-reactivity be- 
tween the mouse pS2  probe  and another member  of the 
P-domain family which may be present in the uterus. Further 
study should resolve this question. 
Human and mouse nmnmmry gland undergo most of their 
morphogenetic and  functional changes  postnatally, under 
hormonal and growth factor control, via similar processes 
(Topper and Freeman, 1980; Vonderhaar 1988; Coleman et 
al.,  1988;  Robinson et al.,  1991). As the expression of the 
pS2 gene is dependent on oestradiol in tumoral human mam- 
mary epithelial cells (Rio et al.,  1987; Berry et al.,  1989; 
Nunez et al.,  1989;  Henry et al.,  1989;  Wysocki et al., 
1990),  we wondered whether this expression may be rem- 
iniscent of a physiological expression occuring during these 
processes. Thus, the expression of the pS2 gene was inves- 
tigated during the physiological processes of proliferation, 
differentiation and postweaning involution which occur in 
the normal mouse mammary gland. Using Northern blot and 
in situ analysis, no pS2 mRNA was observed in the mouse 
mammary gland from virgin (before and after reaching sex- 
ual  maturity),  pregnant,  lactating,  or  postlactating  mice 
(data not shown). 
pS2 and mSP Genes Exhibit Specific Patterns of 
Expression  in the Adult Mouse Gastrointestinal  Tract 
The pS2 and mSP patterns of expression were investigated 
in the entire mouse gastrointestinal tract in the adult animal. 
In situ hybridization, using 35S-labeled pS2  and raSP  an- 
tisense RNA probes was performed on paraffin embedded 
tissues,  pS2  mRNA was expressed in the gastric mucous 
cells lining the surface epithelium and the pits, regardless of 
the portion of the stomach considered: fundus (Fig. 4, A and 
B), antrum (Fig. 4, E and F) and antrum-pyloric (Fig. 5, A 
and B) regions. In contrast, the mSP mRNA was observed 
in cells confined to the junction between the pits and the base 
of the glands within the fundie mucosa, corresponding pre- 
sumably to the mucous neck cells (Fig. 4, C and D), and in 
the base of the antrum (Fig. 4, G and H) and antrum-pyloric 
(Fig. 5, C and D) glands. Thus, although they are both ob- 
served in the fundus (Fig. 4, A-D), the antrum (Fig. 4, E-H) 
and the antrum-pylor (Fig. 5, A-D), pS2 and mSP mRNAs 
showed a  striking difference in their cellular localization, 
resulting in a complementary pattern of expression. 
In the small intestine, pS2 mRNA could not be detected 
while the mSP gene was strongly expressed within the Brun- 
ner's glands confined to the proximal duodenum (Fig. 5, C 
and D). Neither the pS2 nor the mSP mRNAs were observed 
in the large intestine (data not shown). 
pS2 is Transiently  Coexpressed with mSP within the 
Brunner's Glands during Perinatal Development of the 
Mouse Gastrointestinal  Tract 
In situ hybridization analysis revealed that both pS2 and raSP 
genes are expressed during the perinatal development of the 
gastrointestinal tract, pS2 mRNA was first observed at day 
17 in embryonic stomach, and, at day 18, both pS2 and mSP 
mRNAs were detected in the epithelial cells lining the sur- 
face and the nascent pits and glands, although mSP mRNA 
levels were less intense than those of pS2 mRNA (data not 
shown).  From birth onwards, these patterns of expression 
progressively evolved and a clearcut pattern of pS2 and mSP 
expression, as observed in adult, became apparent within the 
stomach at postnatal day 14. 
In  addition,  18-d  embryos  showed  expression  of both 
mRNAs in the glands of the gastro-duodenal junction corre- 
sponding partly to the developing Brunner's glands (data not 
shown). From birth onwards, the Brnnner's glands, localized 
at the lower intervillus area of the proximal duodenum, were 
strongly stained with the mSP probe (Fig. 5, G and H) and 
showed a transient co-expression of pS2 (Fig. 5, E and F), 
no longer observed postnatal day 14. pS2 and mSP genes 
were never expressed in the developing large intestine (data 
not shown). 
Discussion 
We have identified a  mouse homolog of the human pS2 
cDNA. The putative mouse pS2 protein is well conserved, 
exhibiting  notably a  typical P-domain  (Tomasetto et  al., 
1990)  and a  COOH-terminal acidic motif, previously de- 
scribed only in the human pS2 protein. The mousepS2  gene 
is expressed in the fundic, the antral, and the antrum-pyloric 
Stomach mucosal cells,  but not in the normal mammary 
gland. Moreover, a comparative in situ analysis of the one 
The Journal of Cell Biology, Volume  122, 1993  194 Figure 4. In situ hybridization of pS2 and mSP mRNA in adult mouse stomach. Sections from the fundus (A-D) and the antrum (E-H) 
were hybridized with antisense probes specific for mouse pS2 (.4, B, and E, F) and mSP (C, D, and G, H). Both parts of the stomach 
expressed pS2 and mSP, showing a complementary pattern of expression; (A-D) Fundus, pS2 mRNA in the surface epithelium (Se) and 
the pits (p), mSP mRNA in the neck cells (Nc); (E-H) antrum, pS2 mRNA in the surface epithelium (Se) and in the pits (p), raSP in 
the base of the glands (G). No significant labeling above background was found when using sense mouse pS2 and raSP RNA probes (data 
not shown).  Dark field: (A, C, E, and G) and bright field: (B, D, F, and H) of the same sections. Bar,  160/zm. 
Lefcbvre et al. Identification and Expression of the Mouse  pS2 gene  195 Figure 5. In sire hybridization of pS2 and mSP mRNA in adult (A-D) and perinatal (E-H) mouse duodenum. (A and B) pS2 expression 
in the surface epithelium (Se) and the pits (p) of the pylor (P); (C and D) mSP expression in the Brunner's glands of the proximal part 
of the duodenum (D). (E-H) presence of both pS2 (E and F) and mSP (G and H) mRNAs in the Brunner's gland of the duodenum from 
a new-born mouse, on the day of birth. The villi (V) are negative. No significant labeling above background was found when using sense 
mouse pS2 and mSP RNA probes (data not shown). Dark field (A, C, E, and G) and bright field (B, D, .F, and H) of the same sections. 
Bars: (A-D) 160 #m; (E-H) 80 #m. 
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on the whole mouse gastrointestinal tract showed a distinct 
pattern of expression for the two genes. The pS2 gene is ex- 
pressed in cells located within the surface and the pits, while 
the mSP-expressing cells are the fundic neck cells and basal 
cells of the antral and pyloric glands.  A previous analysis, 
limited to the presumed normal human antrum, showed a co- 
expression of the pS2 and hSP genes, in the superficial epi- 
thelinm  (Tomasetto et al.,  1990).  However, in accordance 
with the present study, no PSP immunoreactivity was seen 
in the surface epithelium and in the pits of the pig stomach 
(Rasmussen et al., 1992). Interestingly, a differential cellular 
localization ofpS2 and hSP gene expression, similar to that 
described here, has already been observed in the ulceration- 
associated cell lineage (UACL) in damaged human small in- 
testine (Wright et al., 1990). This complementary pattern of 
expression  suggests  that,  although  they may  have  similar 
function (Thim,  1988; Baker, 1988), one P-domain and two 
P-domain peptides could act on different regions of the gas- 
trointestinal tract, perhaps locally, in an autocrine manner. 
During  the perinatal  development, pS2 and mSP are al- 
ready coexpressed in immature stomach and duodenum of 
18-d mouse embryos. Adult-like pS2 and mSP pattern of ex- 
pression progressively develops during the two first weeks of 
life,  concomitantly  with the neonate  differentiation  of the 
glands  (Ouellette  and  Cordell,  1988;  Dial  and  Lichten- 
berger, 1989). At 14 d, thepS2 gene is no longer expressed 
in the duodenal Brunner's  glands. 
In human,  the oestradiol-regulated pS2 gene expression 
represents a discriminating  marker  for hormonal  status of 
the breast tumors (Rio et al.,  1987;  Foekens et al.,  1990; 
Henry et al., 1991; Schwartz et al., 1991; Klijn, 1992). Either 
no pS2 expression (Rio et al.,  1987; Skilton et al.,  1989) or 
a weakpS2 expression (Piggott et al.,  1991; H~ihnel et al., 
1991; Predine et al.,  1992) has been observed in the normal 
human mammary gland. Assuming that the regulation of the 
pS2 gene is conserved between human and mouse, the ab- 
sence of pS2 gene expression during the mouse mammary 
gland  postnatal  development,  even at  steps depending  on 
oestrogens and/or EGF (Coleman et al.,  1988; Vonderhaar, 
1988; Snedeker et al.,  1991), suggests that the expression of 
pS2 in human breast carcinomas, does not represent an inap- 
propriate physiological expression.  Moreover, preliminary 
analysis of mouse mammary tumors showed no expression 
of the pS2 gene (data not shown). 
The biological function of the pS2 protein  remains  un- 
known. In addition to its normal expression in the stomach, 
the human pS2 gene is overexpressed in acute inflammatory 
disorders of the gastrointestinal  tract (Wright et al.,  1990; 
Rio et al.,  1991) and in a panel of carcinomas (Rio et al., 
1987;  Luqmani et al.,  1989; Welter et al.,  1991;  Henry et 
al.,  1991a;  Seitz et al.,  1991).  Growth modulating activity, 
protease  inhibitory  function  or gastric  mucosa protective 
effect, have been proposed (Jakowlev et al.,  1984;  Baker, 
1988; Thim,  1989). Due to the large spectrum of possible 
regulating pathways (Berry et al., 1989; Nunez et al.,  1989) 
and expression pattern of the pS2 gene (Rio and Chambon, 
1990; and references therein), one may imagine that the pS2 
protein possesses various tissue specific functions.  Never- 
theless, an overall concept could be proposed.  The human 
and mousepS2 genes are always expressed by mucin-express- 
ing cells, and more precisely by MUCl-expressing tissues, 
i.e., the stomach (Luqmani et al.,  1989), the UACL (Wright 
et al.,  1990b), the mammary gland or the pancreas (Lan et 
al.,  1990; and for review see Spicer et al.,  1991).  Mucins 
are glycoproteins which act as a  barrier  between the cell 
membrane and the external environment (for review see De- 
vine and McKenzie,  1992 and references therein).  Interest- 
ingly,  MUC1  (previously  referred  to  as  the  polymorphic 
epithelial mucin) is mainly associated with breast, ovarian, 
and pancreatic tumors, where it is over-expressed and/or al- 
tered, notably in its carbohydrate structures (Hilkens, 1988; 
Merlo et al.,  1989; McKenzie and Xing,  1990;  Ceriani et 
al.,  1992).  Thus,  there is a relationship  between the pS2- 
expressing tissues,  and it is tempting to speculate that the 
pS2 protein biological function is related to the MUC1 sub- 
type of mucins. In this context, it has already been proposed 
that the pS2 protein may play a role in the degradation of the 
carbohydrate and of the tumoral extracellular glycoproteins 
(Tomasetto et al.,  1990). 
Finally,  due to their similar sequence and pattern of ex- 
pression, a comparable function can be expected for the hu- 
man and mouse pS2 proteins. The knowledge of the mouse 
homolog of the pS2 cDNA provides the basis for systematic 
molecular biological research on animal models. The physi- 
ological function of the pS2 protein will be investigated in 
transgenic mice, through gene disruption in embryonic stem 
cells. More applied studies should also be initiated to estab- 
lish the precise participation and the possible clinical impli- 
cations  of the pS2 protein  in gastrointestinal  pathological 
processes. 
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